NanoViricides Inc (NYSEMKT:NNVC) was the recipient of a significant decline in short interest in October. As of October 31st, there was short interest totalling 1,476,924 shares, a decline of 20.2% from the October 13th total of 1,851,692 shares. Approximately 3.1% of the company’s stock are short sold. Based on an average daily volume of 243,752 shares, the short-interest ratio is currently 6.1 days.

NanoViricides (NNVC) remained flat at $$1.00 during midday trading on Monday. 60,965 shares of the company were exchanged, compared to its average volume of 144,916. NanoViricides has a fifty-two week low of $0.91 and a fifty-two week high of $1.64.

Separately, BidaskClub cut shares of NanoViricides from a “sell” rating to a “strong sell” rating in a research note on Saturday, November 4th.

COPYRIGHT VIOLATION WARNING: This piece of content was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2017/11/13/nanoviricides-inc-nnvc-short-interest-down-20-2-in-october.html.

NanoViricides Company Profile

NanoViricides, Inc is a nano-biopharmaceutical company. The Company is a development-stage company with several drugs in various stages of development. The Company focuses on its research and clinical programs on specific anti-viral therapeutics. The Company is engaged in the application of nanomedicine technologies to the issues of viral diseases.

Receive News & Ratings for NanoViricides Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoViricides Inc and related companies with MarketBeat.com's FREE daily email newsletter.